Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma-Reference-Cited by-同舟云学术

Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma

Published:2021-11 Issue: Volume: Page:
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Yamada Toru,Nakanishi Yoshitsugu^ORCID,Hayashi Hideyuki^ORCID,Tanishima Shigeki,Mori Ryo,Fujii Kyoko,Okamura Keisuke,Tsuchikawa Takahiro,Nakamura Toru,Noji Takehiro,Asano Toshimichi,Matsui Aya,Tanaka Kimitaka^ORCID,Watanabe Yusuke,Kurashima Yo^ORCID,Ebihara Yuma,Murakami Soichi,Shichinohe Toshiaki,Mitsuhashi Tomoko,Hirano Satoshi

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference45 articles.

1. Pathogenesis, diagnosis, and management of cholangiocarcinoma;Rizvi;Gastroenterology,2013

2. Cholangiocarcinoma: current knowledge and new developments;Blechacz;Gut Liver,2017

3. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution;DeOliveira;Ann Surg,2007

4. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections;Nagino;Ann Surg,2013

5. Time to recurrence after surgical resection and survival after recurrence among patients with perihilar and distal cholangiocarcinomas;Nakanishi;Ann Surg Oncol,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The construction of a prognostic model by apoptosis-related genes to predict survival, immune landscape, and medication in cholangiocarcinoma;Clinics and Research in Hepatology and Gastroenterology;2024-10

2. Infigratinib for the Treatment of Metastatic or Locally Advanced Cholangiocarcinoma With Known FGFR2 Gene Fusions or Rearrangements;Cureus;2023-10-10